16 Sep 2018

BioMarin Expands its Cork Facility

BioMarin has announced plans to extend its facility in Shanbally, Cork to develop a new Drug Product Filling Project. The investment is estimated at approximately $43 million and is projected to create an additional 51 jobs across all disciplines, and will augment the site’s Drug Substance Manufacturing and Secondary Packaging and Labelling capability.

Welcoming the announcement, An Tánaiste and Minster for Foreign Affairs and Trade, Simon Coveney TD said “Today’s announcement is an exciting development for BioMarin, a company which has thrived in the Cork biopharmaceutical cluster. This investment will not only bring opportunities for regional employment but also positive knock-on effects for the local economy.”

Executive Director of IDA Ireland Mary Buckley said “I am delighted to welcome BioMarin’s latest investment. As a global leader in the manufacturing of treatments for rare diseases, the company has quickly gone from strength to strength in Ireland. The Shanbally operation is ideally positioned to accommodate this latest expansion due to the existing skill base and the proven track record of success in Cork over the past 7 years. Today’s high value investment in Cork further consolidates Ireland’s position globally as a location of choice for biopharmaceuticals”.